Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review

por Fusi-Rubiano, William, Blow, Rebecca R., Lane, Mark, Morjaria, Rupal, Denniston, Alastair K.
Publicado 2018

Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review

por Fusi-Rubiano, William, Blow, Rebecca R., Lane, Mark, Morjaria, Rupal, Denniston, Alastair K.
Publicado 2020

Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years’ Real-World Clinical Outcomes

por Horner, Faye, Lip, Peck Lin, Mohammed, Bashar R, Fusi-Rubiano, William, Gokhale, Eesha, Mushtaq, Bushra, Chavan, Randhir
Publicado 2021

Retinal embolic events: frequency and impact following transcatheter aortic valve implantation (TAVI) for aortic stenosis

por Fusi-Rubiano, William J, Yang, Yit C, Smallwood, Andrew F, Chavan, Randhir C, Khogali, Saib, Narendran, Nirodhini, Cotton, James M
Publicado 2017

Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years

por Fusi-Rubiano, William, Mukherjee, Chandoshi, Lane, Mark, Tsaloumas, Marie D., Glover, Nicholas, Kidess, Andrej, Denniston, Alastair K., Palmer, Helen E., Manna, Avinash, Morjaria, Rupal
Publicado 2018